ALSO NOTED: Archimedes buys Link; Generex plans human bird flu trial;and much more...

Tools

> The UK's Archimedes Pharma has acquired Link Holdings, a UK-based pharmaceuticals group that focuses on sales and marketing of specialty pharmaceuticals with commercial operations in the UK, France and Germany. Report

> Generex has entered into an agreement with the Lebanese-Canadian Hospital in Beirut, Lebanon to conduct a human clinical trial of the Antigen Express synthetic avian influenza vaccine, representing the first studies to be conducted in man. Release

> The new federal drug benefit has proven to be a big winner for big pharma. Report

> Poniard is touting positive interim survival data from a Phase II trial of picoplatin in patients with small cell lung cancer. Release

> Isogenica has signed a pact with UCB to employ its CIS display technology to identify peptide ligands to an undisclosed target. Report

And Finally... The recent Sirna deal has focused new attention on the tiny biotech Benitec, which has been active in gene silencing research. Report